Necrolytic migratory erythema as the first manifestation of glucagonoma
- PMID: 22970401
- PMCID: PMC3434377
- DOI: 10.1155/2012/974210
Necrolytic migratory erythema as the first manifestation of glucagonoma
Abstract
Necrolytic migratory erythma (NME) as a rare skin disorder that can affected Perineum, distal extremities, lower abdomen and face are the most commonly affected sites.It can be as a part of Glucagonoma syndrome that is defined as an association of glucagonoma with NME, hyperglucagonemia, glucose intolerance, anemia and weight loss. Here, Authors describe a woman admitted to the dermatology ward with NME which was later found to be associated with glucagonoma and multiple hepatic lesions.
References
-
- Becker SW, Brennan BB. Benign and malignant cutaneous tumors in the elderly. Archives of Dermatology. 1961;83:262–271. - PubMed
-
- McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME. A glucagon-secreting alpha-cell carcinoma of the pancreas. The New England Journal of Medicine. 1966;274(25):1408–1413. - PubMed
-
- Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B. A glucagonoma syndrome. The Lancet. 1974;2(7871):1–5. - PubMed
-
- van Beek AP, de Haas ERM, van Vloten WA, Lips CJM, Roijers JFM, Canninga-van Dijk MR. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. European Journal of Endocrinology. 2004;151(5):531–537. - PubMed
LinkOut - more resources
Full Text Sources
